Working… Menu

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03283761
Recruitment Status : Recruiting
First Posted : September 14, 2017
Last Update Posted : November 17, 2020
Celgene Corporation
Big Ten Cancer Research Consortium
Information provided by (Responsible Party):
Al B. Benson, III, MD, Big Ten Cancer Research Consortium

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : August 30, 2022